Experimental shock drug tested in healthy volunteers for first time
NCT ID NCT06331884
Summary
This study tested the safety of an experimental drug called AK1967 (Procizumab) in healthy men. The drug is being developed as a potential treatment for cardiogenic shock, a life-threatening heart condition. Researchers gave single doses to 24 healthy male volunteers to check for side effects and see how the drug moves through the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Radboud University Medical Center
Nijmegen, Gelderland, 6525, Netherlands
Conditions
Explore the condition pages connected to this study.